Low antiangiogenic ratio (e.g sFlt-1/PlGF <38) in maternal circulation in populations with suspected preeclampsia also predict the absence of placenta-associated adverse outcomes, both preeclampsia [12] and early-onset FGR [11–15]. The gene discussed is PGF; the disease is preeclampsia.